Advertisement

Topics

Xdynia LLC Company Profile

18:26 EDT 17th June 2018 | BioPortfolio

Xdynia LLC is a Charlottesville, Virginia based preclinical pharmaceutical company developing drugs that inhibit Cav3.2 for the treatment of neuropathic pain, chemotherapy-induced neuropathy, and tremor. Xdynia's library of Cav3.2 inhibitors were developed by world experts in T-type calcium channels.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Xdynia LLC

Xdynia LLC is a Charlottesville, Virginia based preclinical pharmaceutical company developing drugs that inhibit Cav3.2 for the treatment of neuropathic pain, chemotherapy-induced...

More Information about "Xdynia LLC" on BioPortfolio

We have published hundreds of Xdynia LLC news stories on BioPortfolio along with dozens of Xdynia LLC Clinical Trials and PubMed Articles about Xdynia LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xdynia LLC Companies in our database. You can also find out about relevant Xdynia LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record